Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1
Published November 15, 2023 · Recall initiated: November 6, 2023
Summary
FDA records drug Class III recall D-0089-2024, published November 15, 2023 and initiated November 6, 2023. Recalling firm: Taro Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 11,196 bottles; Lot: Lot# AC86809, AC86812, Exp Date: 01/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if HYDROCORTISONE AND ACETIC ACID has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROCORTISONE AND ACETIC ACID
- Manufacturer
- Taro Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot# AC86809, AC86812, Exp Date: 01/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDASynthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. NorthNovember 15, 2023
- FDAExtended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLCNovember 15, 2023
- FDABuprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial,November 15, 2023
- FDAClinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0%November 15, 2023
- FDAMontelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories.,November 15, 2023
- FDARanolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: GlenmarkNovember 15, 2023
Questions about this recall
Was Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1 recalled?
Yes. FDA published recall D-0089-2024 on November 15, 2023. Reported hazard: Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROCORTISONE AND ACETIC ACID.